These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3963663)
21. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Henderson DK; Fahey BJ; Willy M; Schmitt JM; Carey K; Koziol DE; Lane HC; Fedio J; Saah AJ Ann Intern Med; 1990 Nov; 113(10):740-6. PubMed ID: 2240876 [TBL] [Abstract][Full Text] [Related]
22. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332 [TBL] [Abstract][Full Text] [Related]
23. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [TBL] [Abstract][Full Text] [Related]
25. Update: prospective evaluation of health-care workers exposed via the parenteral or mucous-membrane route to blood or body fluids from patients with acquired immunodeficiency syndrome--United States. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):101-3. PubMed ID: 3918247 [TBL] [Abstract][Full Text] [Related]
26. HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients. Lawrence DN; Jason JM; Bouhasin JD; McDougal JS; Knutsen AP; Evatt BL; Joist JH Blood; 1985 Sep; 66(3):703-5. PubMed ID: 2992640 [TBL] [Abstract][Full Text] [Related]
27. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659 [TBL] [Abstract][Full Text] [Related]
28. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study. Jaffe HW; Darrow WW; Echenberg DF; O'Malley PM; Getchell JP; Kalyanaraman VS; Byers RH; Drennan DP; Braff EH; Curran JW Ann Intern Med; 1985 Aug; 103(2):210-4. PubMed ID: 2990275 [TBL] [Abstract][Full Text] [Related]
29. Virologic studies in a case of transfusion-associated AIDS. Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957 [TBL] [Abstract][Full Text] [Related]
30. Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. Friedland GH; Saltzman BR; Rogers MF; Kahl PA; Lesser ML; Mayers MM; Klein RS N Engl J Med; 1986 Feb; 314(6):344-9. PubMed ID: 3456076 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R; Redfield RR; Broder S J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028 [TBL] [Abstract][Full Text] [Related]
32. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Vogt MW; Witt DJ; Craven DE; Byington R; Crawford DF; Schooley RT; Hirsch MS Lancet; 1986 Mar; 1(8480):525-7. PubMed ID: 2869261 [TBL] [Abstract][Full Text] [Related]
33. Infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus: considerations for transmission in the child day care setting. MacDonald KL; Danila RN; Osterholm MT Rev Infect Dis; 1986; 8(4):606-12. PubMed ID: 3018893 [TBL] [Abstract][Full Text] [Related]
34. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services. Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202 [TBL] [Abstract][Full Text] [Related]
36. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168 [TBL] [Abstract][Full Text] [Related]
37. AIDS: just the facts from specialists at Johns Hopkins. Finkbeiner A Johns Hopkins Mag; 1985 Dec; ():23-8. PubMed ID: 12314201 [TBL] [Abstract][Full Text] [Related]
38. Transfusion-associated acquired immunodeficiency syndrome in the United States. Peterman TA; Jaffe HW; Feorino PM; Getchell JP; Warfield DT; Haverkos HW; Stoneburner RL; Curran JW JAMA; 1985 Nov 22-29; 254(20):2913-7. PubMed ID: 2997493 [TBL] [Abstract][Full Text] [Related]
39. HIV and HTLV-I infections in the Americas: a regional perspective. Quinn TC; Zacarias FR; St John RK Medicine (Baltimore); 1989 Jul; 68(4):189-209. PubMed ID: 2544782 [TBL] [Abstract][Full Text] [Related]
40. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. Margolick JB; Volkman DJ; Folks TM; Fauci AS J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]